JP Patent

JP2012236850A — 新規調製方法、塩、組成物及び使用

Assigned to Glaxo Group Ltd · Expires 2012-12-06 · 13y expired

What this patent protects

【課題】局所投与用新規医薬組成物又は製剤、及び薬物療法(特に、抗菌療法)の提供。 【解決手段】下式で示されるムチリン14-(エキソ-8-メチル-8-アザビシクロ[3.2.1]オクト-3-イルスルファニル)アセテートの新規塩又はその溶媒和物。 【選択図】図１５

USPTO Abstract

【課題】局所投与用新規医薬組成物又は製剤、及び薬物療法(特に、抗菌療法)の提供。 【解決手段】下式で示されるムチリン14-(エキソ-8-メチル-8-アザビシクロ[3.2.1]オクト-3-イルスルファニル)アセテートの新規塩又はその溶媒和物。 【選択図】図１５

Drugs covered by this patent

Patent Metadata

Patent number
JP2012236850A
Jurisdiction
JP
Classification
—
Expires
2012-12-06
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.